anmelden
OMX Nordic 40
2.711,69
PKT
-3,84
PKT
-0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.02.21 | Volvo (B) overweight | JP Morgan Chase & Co. | |
| 03.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 03.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.02.21 | Novo Nordisk Neutral | UBS AG | |
| 03.02.21 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 03.02.21 | Volvo (B) buy | Jefferies & Company Inc. | |
| 03.02.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.02.21 | Kone Underperform | Jefferies & Company Inc. | |
| 01.02.21 | Nokia Neutral | Credit Suisse Group | |
| 01.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 01.02.21 | Hennes Mauritz (H M, H&M) buy | Kepler Cheuvreux | |
| 01.02.21 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Deutsche Bank AG | |
| 01.02.21 | Ericsson (Telefon L.M.Ericsson) (B) Outperform | Credit Suisse Group | |
| 29.01.21 | Kone overweight | JP Morgan Chase & Co. | |
| 29.01.21 | Ericsson (Telefon L.M.Ericsson) (B) overweight | JP Morgan Chase & Co. | |
| 26.01.21 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.01.21 | AstraZeneca Neutral | UBS AG | |
| 26.01.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 25.01.21 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 25.01.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 22.01.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 22.01.21 | Volvo (B) Neutral | UBS AG | |
| 22.01.21 | AstraZeneca overweight | Barclays Capital | |
| 22.01.21 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 22.01.21 | Kone Sell | UBS AG | |
| 20.01.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 20.01.21 | Novo Nordisk Neutral | Credit Suisse Group | |
| 20.01.21 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 20.01.21 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 18.01.21 | Volvo (B) buy | Goldman Sachs Group Inc. | |
| 18.01.21 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 18.01.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 18.01.21 | Kone Neutral | Goldman Sachs Group Inc. | |
| 15.01.21 | Novo Nordisk buy | Deutsche Bank AG | |
| 15.01.21 | AstraZeneca buy | Deutsche Bank AG | |
| 15.01.21 | ABB (Asea Brown Boveri) Equal weight | Barclays Capital | |
| 15.01.21 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.01.21 | A.P. Moeller - Maersk A-S (B) overweight | Morgan Stanley | |
| 14.01.21 | Volvo (B) Outperform | Bernstein Research | |
| 14.01.21 | AstraZeneca Neutral | UBS AG |
